Idorsia submits a new drug application to the FDA

admin 2 years ago No Comments

This post was originally published on this site

Aprocitentan is intended to be used in the treatment of patients with difficult-to-control hypertension. Idorsia included data from a comprehensive clinical and non-clinical development program in the application.

Prev Article Next Article

China’s Factory Deflation Deepens in September

admin October 15, 2019

Meta wins appeal against block of Giphy deal by UK regulator

admin June 14, 2022

France stocks higher at close of trade; CAC 40 up 1.14%

admin December 1, 2020

UK’s Metro Bank rejected takeover approaches from specialist lender Shawbrook-Sky News

admin October 7, 2023

Orange’s quarterly sales boosted by Africa and Middle East

admin April 26, 2022

Bed Bath & Beyond interim CEO to stay in post for at least a year – source

admin September 14, 2022

About The Author

admin

in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

By signing up above you will receive the Daily Buzz Offers newsletter and 3rd party advertisements. Expect up to 5 messages per week from us. You can unsubscribe at any time at the bottom of any of our emails.

Related Posts

About The Author

admin